The Exchange has sought clarification from Wockhardt with respect to news article appearing on moneycontrol website & CNBCTV18 on September 9, 2015 titled ‘Wockhardt shares rise 5% on USFDA nod for alzheimer drug.’
The above information is a part of company’s filings submitted to BSE.